165 related articles for article (PubMed ID: 17630355)
1. STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells.
Schepers H; van Gosliga D; Wierenga AT; Eggen BJ; Schuringa JJ; Vellenga E
Blood; 2007 Oct; 110(8):2880-8. PubMed ID: 17630355
[TBL] [Abstract][Full Text] [Related]
2. Single-cell STAT5 signal transduction profiling in normal and leukemic stem and progenitor cell populations reveals highly distinct cytokine responses.
Han L; Wierenga AT; Rozenveld-Geugien M; van de Lande K; Vellenga E; Schuringa JJ
PLoS One; 2009 Nov; 4(11):e7989. PubMed ID: 19956772
[TBL] [Abstract][Full Text] [Related]
3. Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires rac-mediated interaction with stromal cells.
Rozenveld-Geugien M; Baas IO; van Gosliga D; Vellenga E; Schuringa JJ
Exp Hematol; 2007 May; 35(5):782-92. PubMed ID: 17577927
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
5. Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases.
Fatrai S; Schepers H; Tadema H; Vellenga E; Daenen SM; Schuringa JJ
Exp Hematol; 2008 Oct; 36(10):1254-65. PubMed ID: 18640764
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells.
Sutherland HJ; Blair A; Zapf RW
Blood; 1996 Jun; 87(11):4754-61. PubMed ID: 8639846
[TBL] [Abstract][Full Text] [Related]
7. Umbilical cord blood from preterm human fetuses is rich in committed and primitive hematopoietic progenitors with high proliferative and self-renewal capacity.
Wyrsch A; dalle Carbonare V; Jansen W; Chklovskaia E; Nissen C; Surbek D; Holzgreve W; Tichelli A; Wodnar-Filipowicz A
Exp Hematol; 1999 Aug; 27(8):1338-45. PubMed ID: 10428511
[TBL] [Abstract][Full Text] [Related]
8. Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation.
Piacibello W; Sanavio F; Garetto L; Severino A; Dané A; Gammaitoni L; Aglietta M
Leukemia; 1998 May; 12(5):718-27. PubMed ID: 9593270
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
10. STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPalpha.
Wierenga AT; Schepers H; Moore MA; Vellenga E; Schuringa JJ
Blood; 2006 Jun; 107(11):4326-33. PubMed ID: 16455947
[TBL] [Abstract][Full Text] [Related]
11. IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo.
Yang J; Ikezoe T; Nishioka C; Nobumoto A; Yokoyama A
Int J Cancer; 2013 Oct; 133(8):1967-81. PubMed ID: 23564444
[TBL] [Abstract][Full Text] [Related]
12. A critical role for SHP2 in STAT5 activation and growth factor-mediated proliferation, survival, and differentiation of human CD34+ cells.
Li L; Modi H; McDonald T; Rossi J; Yee JK; Bhatia R
Blood; 2011 Aug; 118(6):1504-15. PubMed ID: 21670473
[TBL] [Abstract][Full Text] [Related]
13. Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis.
Rizo A; Olthof S; Han L; Vellenga E; de Haan G; Schuringa JJ
Blood; 2009 Aug; 114(8):1498-505. PubMed ID: 19556423
[TBL] [Abstract][Full Text] [Related]
14. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
[TBL] [Abstract][Full Text] [Related]
15. ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML.
Capala ME; Vellenga E; Schuringa JJ
PLoS One; 2014; 9(10):e111568. PubMed ID: 25360637
[TBL] [Abstract][Full Text] [Related]
16. Identification of HIF2alpha as an important STAT5 target gene in human hematopoietic stem cells.
Fatrai S; Wierenga AT; Daenen SM; Vellenga E; Schuringa JJ
Blood; 2011 Mar; 117(12):3320-30. PubMed ID: 21263150
[TBL] [Abstract][Full Text] [Related]
17. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
18. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia.
Inoue K; Ogawa H; Sonoda Y; Kimura T; Sakabe H; Oka Y; Miyake S; Tamaki H; Oji Y; Yamagami T; Tatekawa T; Soma T; Kishimoto T; Sugiyama H
Blood; 1997 Feb; 89(4):1405-12. PubMed ID: 9028964
[TBL] [Abstract][Full Text] [Related]
19. Stable transduction with lentiviral vectors and amplification of immature hematopoietic progenitors from cord blood of preterm human fetuses.
Luther-Wyrsch A; Costello E; Thali M; Buetti E; Nissen C; Surbek D; Holzgreve W; Gratwohl A; Tichelli A; Wodnar-Filipowicz A
Hum Gene Ther; 2001 Mar; 12(4):377-89. PubMed ID: 11242530
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation.
Schuringa JJ; Chung KY; Morrone G; Moore MA
J Exp Med; 2004 Sep; 200(5):623-35. PubMed ID: 15353555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]